1. Waites KB, Cassell GH, Canup KC, Fernandes PB: In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones. Antimicrobial Agents and Chemotherapy 1988, 32: 1500–1502.
2. Rylander M, Hallander HO: In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide CP-62,993, againstMycoplasma pneumoniae, Mycoplasma hominis andUreaplasma urealyticum. Scandinavian Journal of Infectious Diseases 1988, Supplement 3: 12–17.
3. Bébéar C, Cantet P, Renaudin H, Quentin C: Activité comparée de la minocycline et de la doxycycline sur les mycoplasmes pathogènes pour l'homme. Pathologie Biologie 1985, 33: 577–580.
4. Bébéar C, de Barbeyrac B, Bernet C, Renaudin H: Méthodes d'exploration des infections à mycoplasmes. Annales de Biologie Clinique 1989, 47: 415–420.
5. Kenny GE, Hooton TM, Roberts MC, Cartwright FD, Hoyt J: Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method. Antimicrobial Agents and Chemotherapy 1989, 33: 103–107.